|
|
Volumn 36, Issue 6, 2004, Pages 1647-1649
|
|
Stable renal transplant recipients can be safely converted from MMF to enteric-coated mycophenolate sodium tablets: Interim results of a multicenter Latin American study
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MYCOPHENOLIC ACID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
ABDOMINAL PAIN;
ADULT;
CHILD;
CHOLELITHIASIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DATA ANALYSIS;
DIARRHEA;
DRUG COATING;
DRUG DOSE REDUCTION;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
GASTROINTESTINAL TOXICITY;
GRAFT REJECTION;
HUMAN;
HYPERURICEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL ASSESSMENT;
MULTICENTER STUDY;
NEUTROPENIA;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
CHILD;
CONTINENTAL POPULATION GROUPS;
ETHNIC GROUPS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LATIN AMERICA;
MALE;
MYCOPHENOLIC ACID;
TABLETS, ENTERIC-COATED;
TIME FACTORS;
|
|
EID: 4444331622
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.07.031 Document Type: Conference Paper |
|
Times cited : (16)
|
|
References (13)
|
